Fernanda Aleixo

About the Speaker
  • Profession
    Mylan
  • Company
    Director, Policy & Market Access
  • Web Sites

Fernanda Maria Gonçalves Aragão Aleixo, Director, Policy & Market Access at Mylan

Fernanda Aleixo is specialist in Regulatory Affairs and member of the council of specialists of the National Association of Pharmacists.

Involved in the launch of first biosimilars medicines in Portugal; Epoetin (2008), Filgrastim (2010) and Infliximab (2013)

Leader of the Technical Commission of Apogen (the trade association for generic and biosimilars medicines) from 2012-2015, and from 2016 until now.

Developed several activities with different stakeholders aiming to increase the education of the science behind the biosimilars medicines with the goal to share their value for the society, to increase the confidence on these health technologies, and to contribute for more rational and conscientious decisions.

Jul. 2016 –
Policy and Market Access Director at Mylan
Responsible by:

  • Market Access and Governmental Affairs mainly with biosimilars and branded medicines
  • Scientific Affairs associated with market access activities (CVDs, BIMs, economic analysis)
  • Shaping the legal system aiming more efficient processes with gains for patients, National Health System and Companies

Sep. 2003 – Apr.2016
Technical and Regulatory Affairs Director of an international company (Hospira, now a Pfizer company)
Responsible by:

  • Regulatory Affairs including the Market Access and Governmental Affairs
  • Scientific Affairs (including training of commercial team)
  • Quality and Vigilance,
  • Medical Affairs until the end of June.2013

Jun. 1997 – Aug. 2003
Technical and Regulatory Affairs Director of a multinational company (Almirall)
Responsible by:

  • Regulatory Affairs including the market access
  • Quality and Pharmacovigilance,
  • Scientific Affairs (including training of commercial team)

Mar. 1996 – June 1997:
Technical and Regulatory Affairs Director of an international company (Dakota, a Sanofi company)
Responsible by:

  • Regulatory Affairs including the pricing and support of business development of the unit
  • Quality and Pharmacovigilance

Mar. 1990 – March 1996:
Technical and Regulatory Affairs Director of a multinational company (Hikma)

Responsible by:

  • Regulatory Affairs including the Pricing and Public Affairs
  • Quality

Mar. 1988 – Feb.1990
Technical and Regulatory Director of a national company, from March 1988 to March 1990 (Tecnimede)